[{"datasetId":"de96b74593883eb3719acf6b7d2fcd77","mgiGeneAccessionId":"MGI:1922702","pipelineStableId":"BCM_001","procedureStableId":"IMPC_VIA_002","procedureName":"Viability Primary Screen","parameterStableId":"IMPC_VIA_063_001","parameterName":"Homozygous males viability","alleleAccessionId":"MGI:5548657","alleleName":"targeted mutation 1b, Wellcome Trust Sanger Institute","alleleSymbol":"Ascc2<tm1b(EUCOMM)Wtsi>","zygosity":"homozygote","phenotypingCentre":"BCM","sex":"male","projectName":"BaSH","pValue":0.0,"lifeStageName":"Early adult","effectSize":1.0,"phenotype":{"id":"MP:0011100","name":"preweaning lethality, complete penetrance"},"topLevelPhenotypes":[{"id":"MP:0010768","name":"mortality/aging"}],"intermediatePhenotypes":[{"id":"MP:0010769","name":"abnormal survival"},{"id":"MP:0010770","name":"preweaning lethality"}],"dataType":"line","assertionType":"manual"},{"datasetId":"be4e7ae6ac9f572798e81cb517bdd458","mgiGeneAccessionId":"MGI:1922702","pipelineStableId":"BCM_001","procedureStableId":"IMPC_ECH_001","procedureName":"Echo","parameterStableId":"IMPC_ECH_007_001","parameterName":"LVAWd","alleleAccessionId":"MGI:5548657","alleleName":"targeted mutation 1b, Wellcome Trust Sanger Institute","alleleSymbol":"Ascc2<tm1b(EUCOMM)Wtsi>","zygosity":"heterozygote","phenotypingCentre":"BCM","sex":"male","projectName":"BaSH","pValue":1.04888699665833E-6,"lifeStageName":"Early adult","effectSize":-1.35374691480962,"phenotype":{"id":"MP:0010580","name":"decreased heart left ventricle size"},"topLevelPhenotypes":[{"id":"MP:0005385","name":"cardiovascular system phenotype"}],"intermediatePhenotypes":[{"id":"MP:0010578","name":"abnormal heart left ventricle size"},{"id":"MP:0031543","name":"abnormal heart ventricle size"},{"id":"MP:0000266","name":"abnormal heart morphology"},{"id":"MP:0031544","name":"decreased heart ventricle size"},{"id":"MP:0003921","name":"abnormal heart left ventricle morphology"},{"id":"MP:0002127","name":"abnormal cardiovascular system morphology"},{"id":"MP:0005294","name":"abnormal heart ventricle morphology"}],"dataType":"unidimensional","assertionType":"automatic"},{"datasetId":"535345928c75f1c4c304150534f7274f","mgiGeneAccessionId":"MGI:1922702","pipelineStableId":"BCM_001","procedureStableId":"IMPC_VIA_002","procedureName":"Viability Primary Screen","parameterStableId":"IMPC_VIA_067_001","parameterName":"Homozygous animals viability","alleleAccessionId":"MGI:5008937","alleleName":"targeted mutation 1a, Wellcome Trust Sanger Institute","alleleSymbol":"Ascc2<tm1a(EUCOMM)Wtsi>","zygosity":"homozygote","phenotypingCentre":"BCM","sex":"not_considered","projectName":"BaSH","pValue":0.0,"lifeStageName":"Early adult","effectSize":1.0,"phenotype":{"id":"MP:0011100","name":"preweaning lethality, complete penetrance"},"topLevelPhenotypes":[{"id":"MP:0010768","name":"mortality/aging"}],"intermediatePhenotypes":[{"id":"MP:0010769","name":"abnormal survival"},{"id":"MP:0010770","name":"preweaning lethality"}],"dataType":"line","assertionType":"manual"},{"datasetId":"071c2b4751391b776dca0a39adfec784","mgiGeneAccessionId":"MGI:1922702","pipelineStableId":"BCM_001","procedureStableId":"IMPC_CSD_003","procedureName":"Combined SHIRPA and Dysmorphology","parameterStableId":"IMPC_CSD_038_001","parameterName":"Trunk curl","alleleAccessionId":"MGI:5008937","alleleName":"targeted mutation 1a, Wellcome Trust Sanger Institute","alleleSymbol":"Ascc2<tm1a(EUCOMM)Wtsi>","zygosity":"heterozygote","phenotypingCentre":"BCM","sex":"not_considered","projectName":"BaSH","pValue":7.1694268846834E-7,"lifeStageName":"Early adult","effectSize":0.242440151196976,"phenotype":{"id":"MP:0001512","name":"trunk curl"},"topLevelPhenotypes":[{"id":"MP:0005386","name":"behavior/neurological phenotype"}],"intermediatePhenotypes":[{"id":"MP:0004924","name":"abnormal behavior"},{"id":"MP:0002066","name":"abnormal motor capabilities/coordination/movement"},{"id":"MP:0001504","name":"abnormal posture"}],"dataType":"categorical","assertionType":"automatic"},{"datasetId":"878451b233b485e6c312b3527ec7f9e5","mgiGeneAccessionId":"MGI:1922702","pipelineStableId":"BCM_001","procedureStableId":"IMPC_HIS_003","procedureName":"Histopathology","parameterStableId":"IMPC_HIS_033_002","parameterName":"Heart - MPATH pathological process term","alleleAccessionId":"MGI:5548657","alleleName":"targeted mutation 1b, Wellcome Trust Sanger Institute","alleleSymbol":"Ascc2<tm1b(EUCOMM)Wtsi>","zygosity":"heterozygote","phenotypingCentre":"BCM","sex":"male","projectName":"BaSH","pValue":0.0,"lifeStageName":"Early adult","effectSize":1.0,"phenotype":{"id":"MPATH:159","name":"hypertrophy"},"topLevelPhenotypes":[],"intermediatePhenotypes":[{"id":"MPATH:596","name":"pathological process"},{"id":"MPATH:1000","name":"pathological phenotype observation"},{"id":"MPATH:604","name":"defective growth and differentiation process"},{"id":"MPATH:0","name":"pathological entity"}],"dataType":"histopathology","assertionType":"manual"},{"datasetId":"57f191e24a3f383fcdcd19b662a66e30","mgiGeneAccessionId":"MGI:1922702","pipelineStableId":"BCM_001","procedureStableId":"IMPC_EVL_001","procedureName":"Viability E9.5 Secondary Screen","parameterStableId":"IMPC_EVL_001_001","parameterName":"Outcome","alleleAccessionId":"MGI:5548657","alleleName":"targeted mutation 1b, Wellcome Trust Sanger Institute","alleleSymbol":"Ascc2<tm1b(EUCOMM)Wtsi>","zygosity":"homozygote","phenotypingCentre":"BCM","sex":"not_considered","projectName":"BaSH","pValue":0.0,"lifeStageName":"E9.5","effectSize":1.0,"phenotype":{"id":"MP:0013292","name":"embryonic lethality prior to organogenesis"},"topLevelPhenotypes":[{"id":"MP:0010768","name":"mortality/aging"}],"intermediatePhenotypes":[{"id":"MP:0010769","name":"abnormal survival"},{"id":"MP:0002080","name":"prenatal lethality"},{"id":"MP:0010770","name":"preweaning lethality"},{"id":"MP:0008762","name":"embryonic lethality"},{"id":"MP:0013293","name":"embryonic lethality prior to tooth bud stage"}],"dataType":"embryo","assertionType":"manual"},{"datasetId":"ae2aac8062c64dd84901aea83e2f6472","mgiGeneAccessionId":"MGI:1922702","pipelineStableId":"BCM_001","procedureStableId":"IMPC_VIA_002","procedureName":"Viability Primary Screen","parameterStableId":"IMPC_VIA_064_001","parameterName":"Homozygous females viability","alleleAccessionId":"MGI:5008937","alleleName":"targeted mutation 1a, Wellcome Trust Sanger Institute","alleleSymbol":"Ascc2<tm1a(EUCOMM)Wtsi>","zygosity":"homozygote","phenotypingCentre":"BCM","sex":"female","projectName":"BaSH","pValue":0.0,"lifeStageName":"Early adult","effectSize":1.0,"phenotype":{"id":"MP:0011100","name":"preweaning lethality, complete penetrance"},"topLevelPhenotypes":[{"id":"MP:0010768","name":"mortality/aging"}],"intermediatePhenotypes":[{"id":"MP:0010769","name":"abnormal survival"},{"id":"MP:0010770","name":"preweaning lethality"}],"dataType":"line","assertionType":"manual"},{"datasetId":"63050a74a77b3614b2417fce9ef406a6","mgiGeneAccessionId":"MGI:1922702","pipelineStableId":"BCM_001","procedureStableId":"IMPC_CBC_003","procedureName":"Clinical Chemistry","parameterStableId":"IMPC_CBC_003_001","parameterName":"Chloride","alleleAccessionId":"MGI:5548657","alleleName":"targeted mutation 1b, Wellcome Trust Sanger Institute","alleleSymbol":"Ascc2<tm1b(EUCOMM)Wtsi>","zygosity":"heterozygote","phenotypingCentre":"BCM","sex":"female","projectName":"BaSH","pValue":7.30605472612159E-10,"lifeStageName":"Early adult","effectSize":0.914019024138959,"phenotype":{"id":"MP:0003019","name":"increased circulating chloride level"},"topLevelPhenotypes":[{"id":"MP:0005376","name":"homeostasis/metabolism phenotype"}],"intermediatePhenotypes":[{"id":"MP:0012007","name":"abnormal chloride level"},{"id":"MP:0003018","name":"abnormal circulating chloride level"},{"id":"MP:0001765","name":"abnormal ion homeostasis"},{"id":"MP:0001764","name":"abnormal homeostasis"}],"dataType":"unidimensional","assertionType":"automatic"},{"datasetId":"ed678c4a9df9a6e0dd3df1a6b3f3cd53","mgiGeneAccessionId":"MGI:1922702","pipelineStableId":"BCM_001","procedureStableId":"IMPC_VIA_002","procedureName":"Viability Primary Screen","parameterStableId":"IMPC_VIA_067_001","parameterName":"Homozygous animals viability","alleleAccessionId":"MGI:5548657","alleleName":"targeted mutation 1b, Wellcome Trust Sanger Institute","alleleSymbol":"Ascc2<tm1b(EUCOMM)Wtsi>","zygosity":"homozygote","phenotypingCentre":"BCM","sex":"not_considered","projectName":"BaSH","pValue":0.0,"lifeStageName":"Early adult","effectSize":1.0,"phenotype":{"id":"MP:0011100","name":"preweaning lethality, complete penetrance"},"topLevelPhenotypes":[{"id":"MP:0010768","name":"mortality/aging"}],"intermediatePhenotypes":[{"id":"MP:0010769","name":"abnormal survival"},{"id":"MP:0010770","name":"preweaning lethality"}],"dataType":"line","assertionType":"manual"},{"datasetId":"0e7230c21b401c1f545c7ed514f95ec9","mgiGeneAccessionId":"MGI:1922702","pipelineStableId":"BCM_001","procedureStableId":"IMPC_VIA_002","procedureName":"Viability Primary Screen","parameterStableId":"IMPC_VIA_063_001","parameterName":"Homozygous males viability","alleleAccessionId":"MGI:5008937","alleleName":"targeted mutation 1a, Wellcome Trust Sanger Institute","alleleSymbol":"Ascc2<tm1a(EUCOMM)Wtsi>","zygosity":"homozygote","phenotypingCentre":"BCM","sex":"male","projectName":"BaSH","pValue":0.0,"lifeStageName":"Early adult","effectSize":1.0,"phenotype":{"id":"MP:0011100","name":"preweaning lethality, complete penetrance"},"topLevelPhenotypes":[{"id":"MP:0010768","name":"mortality/aging"}],"intermediatePhenotypes":[{"id":"MP:0010769","name":"abnormal survival"},{"id":"MP:0010770","name":"preweaning lethality"}],"dataType":"line","assertionType":"manual"},{"datasetId":"ccc458f919cf70b874362e862f4b30db","mgiGeneAccessionId":"MGI:1922702","pipelineStableId":"BCM_001","procedureStableId":"IMPC_VIA_002","procedureName":"Viability Primary Screen","parameterStableId":"IMPC_VIA_064_001","parameterName":"Homozygous females viability","alleleAccessionId":"MGI:5548657","alleleName":"targeted mutation 1b, Wellcome Trust Sanger Institute","alleleSymbol":"Ascc2<tm1b(EUCOMM)Wtsi>","zygosity":"homozygote","phenotypingCentre":"BCM","sex":"female","projectName":"BaSH","pValue":0.0,"lifeStageName":"Early adult","effectSize":1.0,"phenotype":{"id":"MP:0011100","name":"preweaning lethality, complete penetrance"},"topLevelPhenotypes":[{"id":"MP:0010768","name":"mortality/aging"}],"intermediatePhenotypes":[{"id":"MP:0010769","name":"abnormal survival"},{"id":"MP:0010770","name":"preweaning lethality"}],"dataType":"line","assertionType":"manual"},{"datasetId":"0d895b1e61ee2ac63fead7e8095bb25e","mgiGeneAccessionId":"MGI:1922702","pipelineStableId":"BCM_001","procedureStableId":"IMPC_PAT_002","procedureName":"Gross Pathology and Tissue Collection","parameterStableId":"IMPC_PAT_016_002","parameterName":"Spleen","alleleAccessionId":"MGI:5008937","alleleName":"targeted mutation 1a, Wellcome Trust Sanger Institute","alleleSymbol":"Ascc2<tm1a(EUCOMM)Wtsi>","zygosity":"heterozygote","phenotypingCentre":"BCM","sex":"female","projectName":"BaSH","pValue":0.0,"lifeStageName":"Early adult","effectSize":1.0,"phenotype":{"id":"MP:0000691","name":"enlarged spleen"},"topLevelPhenotypes":[{"id":"MP:0005387","name":"immune system phenotype"},{"id":"MP:0005378","name":"growth/size/body region phenotype"},{"id":"MP:0005397","name":"hematopoietic system phenotype"}],"intermediatePhenotypes":[{"id":"MP:0000689","name":"abnormal spleen morphology"},{"id":"MP:0013328","name":"visceromegaly"},{"id":"MP:0002224","name":"abnormal spleen size"},{"id":"MP:0002396","name":"abnormal hematopoietic system morphology/development"},{"id":"MP:0000685","name":"abnormal immune system morphology"},{"id":"MP:0031094","name":"organomegaly"},{"id":"MP:0002722","name":"abnormal immune system organ morphology"},{"id":"MP:0002221","name":"abnormal lymph organ size"}],"dataType":"adult-gross-path","assertionType":"manual"},{"datasetId":"0d895b1e61ee2ac63fead7e8095bb25e","mgiGeneAccessionId":"MGI:1922702","pipelineStableId":"BCM_001","procedureStableId":"IMPC_PAT_002","procedureName":"Gross Pathology and Tissue Collection","parameterStableId":"IMPC_PAT_016_002","parameterName":"Spleen","alleleAccessionId":"MGI:5008937","alleleName":"targeted mutation 1a, Wellcome Trust Sanger Institute","alleleSymbol":"Ascc2<tm1a(EUCOMM)Wtsi>","zygosity":"heterozygote","phenotypingCentre":"BCM","sex":"female","projectName":"BaSH","pValue":0.0,"lifeStageName":"Early adult","effectSize":1.0,"phenotype":{"id":"MP:0000691","name":"enlarged spleen"},"topLevelPhenotypes":[{"id":"MP:0005387","name":"immune system phenotype"},{"id":"MP:0005378","name":"growth/size/body region phenotype"},{"id":"MP:0005397","name":"hematopoietic system phenotype"}],"intermediatePhenotypes":[{"id":"MP:0000689","name":"abnormal spleen morphology"},{"id":"MP:0013328","name":"visceromegaly"},{"id":"MP:0002224","name":"abnormal spleen size"},{"id":"MP:0002396","name":"abnormal hematopoietic system morphology/development"},{"id":"MP:0000685","name":"abnormal immune system morphology"},{"id":"MP:0031094","name":"organomegaly"},{"id":"MP:0002722","name":"abnormal immune system organ morphology"},{"id":"MP:0002221","name":"abnormal lymph organ size"}],"dataType":"adult-gross-path","assertionType":"manual"}]